IL6 and gastric neoplasm: Along with disease progression, glycosylation affects proteins involved in complement activation, possibly due to the host’s response to the presence of the stomach tumor, and in acute phase response signaling, possibly due to increased signaling of the pro-inflammatory cytokine, IL-6 [130].